ONCT Overview

Appointment of Dr. Robert Wills: Alpha Cognition Inc. has appointed Dr. Robert Wills to its Board of Directors, effective April 7, 2025, bringing extensive experience in drug development and corporate strategy to support the launch of their Alzheimer's treatment, ZUNVEYL.

John Havens' Departure: John Havens will not seek re-election to the Board for 2025, after contributing since 2018; the company will begin searching for a new independent board member to fill his position.

Oncternal Therapeutics Delisting Announcement: Oncternal Therapeutics plans to file a Form 25 Notification of Delisting with the SEC on March 17, 2025, to remove its securities from Nasdaq after trading was suspended in December 2024. Following this, the company will file a Form 15 to deregister with the SEC, suspending its obligation to file periodic reports.

Company Overview: Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oncology therapies for cancers with significant unmet medical needs, particularly targeting hematological malignancies and prostate cancer.

U.S. Stock Market Performance: U.S. stocks saw gains with the Dow Jones increasing by over 400 points, while consumer discretionary shares rose by 1.6%. However, energy shares fell by 1.8%, and notable stock movements included significant drops for Cassava Sciences and Oncternal Therapeutics.

Global Market Trends: European shares experienced slight increases, while Asian markets closed mixed. Economic indicators showed a decline in Germany's Ifo Business Climate and a drop in the Chicago Fed National Activity Index, alongside a rise in Texas manufacturing activity.

U.S. Stock Market Performance: U.S. stocks mostly rose, with the Dow Jones gaining over 250 points, while real estate shares increased by 1.5%. However, energy shares fell by 0.7%, and notable declines were seen in Cassava Sciences and Oncternal Therapeutics.

Global Market Trends: European markets showed gains, with the eurozone's STOXX 600 up 0.16%, while Asian markets closed mixed. The Chicago Fed National Activity Index fell to -0.40 in October, indicating economic slowdown.

U.S. Stock Market Performance: U.S. stocks rose this morning, with the Dow Jones gaining over 300 points, while consumer discretionary shares increased by 1.6%. Bath & Body Works reported better-than-expected quarterly results and raised its 2024 outlook.

Global Market Trends: European shares were mostly higher, while Asian markets closed mixed. The Chicago Fed National Activity Index fell in October, indicating a decline in economic activity.

Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.

Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.